Should Dynamic Drug Pricing be Incorporated into Cost-Effectiveness Analyses? – Healthcare Economist
Cost-effectiveness analyzes (CEA) aim to examine how new healthcare technologies impact health outcomes and costs throughout a patient's life. While it is ...
That's the clever title of recient American Economic Review post by Cyrus Aghamolla, Pinar Karaca-Mandic, Xuelin Li, ...
Scoping reviews are a type of knowledge synthesis, following a systematic approach to mapping the evidence on a topic and ...
Randomized controlled trials are the gold standard for evaluating treatment effectiveness, but real-world effectiveness may vary. One reason for this is ...
That is the title of a KFF article published last week. Results are based on KFF. 2024 Employer Health Benefits Survey. ...
This year the Nobel Prize in Medicine went to Victor Ambros, currently Professor of Natural Sciences at the University of ...
Recently, the Office of Management and Budget has published new procedures for evaluating government regulation (Circular A-4) and economic policies ...
Paxlovid (nirmatrelvir-ritonavir) is effective in preventing hospitalization and death from COVID-19, but few people use ...
These questions may be more difficult to answer than they seem. While some doctors are completely independent and others ...
My FTI colleagues Mark Van Ert and Krunal Patel summarize some of the new quality measures that will be incorporated into ...
- 1
- 2
- 3
- …
- 11
- Next Page »